Streetbeat News

TGIFF

1933 Industries Inc

http://fridaynightinc.com/

CEO

David Lane

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

3.2M

Volume

High

0.01

P/E Ratio

-0.32

52-wk high

0.02

Low

0.01

Div yield

N/A

52-wk low

0.00

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

Marijuana stocks saw significant movement on January 15, 2024, with Khiron Life Sciences leading the gainers with a 152.73% increase, while MedMen Enterprises experienced a steep decline of 95.71%. Other notable gainers include Global Compliance, CordovaCann, and RIV Capital. The losers' list was topped by AusCann Group Holdings with a 58.82% drop, followed by EnWave and Auxly Cannabis Group.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 12, 2024. Khiron Life Sciences led the gainers with a 152.73% increase, while MedMen Enterprises saw a dramatic 95.71% drop. Other notable gainers include Global Compliance and CordovaCann. Among the losers, AusCann Group Holdings also faced a steep decline. The volatility in these stocks reflects ongoing developments in the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 10, 2024. Choom Holdings, EVIO, Global Hemp Group, Global Compliance, Cannabix Technologies, Body and Mind, Pharmadrug, Neptune Wellness Solutions, and Trees saw gains, with Choom Holdings leading with a 9900% increase. Conversely, Acacia Diversified Holdings led the losers with a 99% decline, followed by significant losses in Cann Gr, Khiron Life Sciences, CordovaCann, Elixinol Wellness, 1933 Industries, Item 9 Labs, Affinor Growers, 4Front Ventures, C21 Investments, Heritage Cannabis Holding, Cresco Labs, Leafbuyer Techs, Trulieve Cannabis, Eastside Distilling, Curaleaf Holdings, Cara Therapeutics, Indiva, Auxly Cannabis Group, RIV Capital, Tilray Brands, Greenlane Holdings, iAnthus Capital Holdings, Psychemedics, SNDL, and SOL Global Investments.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 9:30 pm

Marijuana stocks experienced significant movement on a recent Monday, with Australis Capital, EVIO, and several others posting substantial gains, while a few companies like Rocky Mountain High and MJ Holdings faced declines. The article lists the percentage changes and closing prices for the gainers and losers in the sector.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 4, 2024. EVIO led the gainers with a 4900% increase, while AusCann Group Holdings saw the largest decline, dropping 37.98%. Other notable gainers include Khiron Life Sciences and Cannabix Technologies. Among the losers, Psychemedics and Global Compliance also saw substantial drops in their share prices.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.